Argenx SE annual operating cash flow
2019
2020
2021
2022
2023
2024
2025
Argenx SE Operating Cash Flow Growth & History (ARGX)
Argenx SE's operating cash flow was $685.2M for fiscal 2025.
View full Argenx SE company overviewArgenx SE annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $685.2M | $767.9M | — |
| 2024 | 2024-12-31 | −$82.7M | $337.6M | — |
| 2023 | 2023-12-31 | −$420.3M | $442.5M | — |
| 2022 | 2022-12-31 | −$862.8M | −$256.0M | — |
| 2021 | 2021-12-31 | −$606.8M | −$208.3M | — |
| 2020 | 2020-12-31 | −$398.5M | −$550.1M | — |
| 2019 | 2019-12-31 | $151.6M | — | — |
Argenx SE operating cash flow trends
Over the last five fiscal years, Argenx SE's operating cash flow increased from −$398.5M to $685.2M, a change of $1.08B.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Argenx SE source filings ↗Community posts
Argenx sales expand as additional clinical and regulatory work advances
Argenx ($ARGX) reported third-quarter 2026 product sales of approximately $1.7 billion, an increase of 54% from a year earlier and 13% from the preceding quarter. Net profit attributable to shareholders increased to $506 million from $344 m ...
